0001209191-22-045494.txt : 20220811 0001209191-22-045494.hdr.sgml : 20220811 20220811190148 ACCESSION NUMBER: 0001209191-22-045494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220810 FILED AS OF DATE: 20220811 DATE AS OF CHANGE: 20220811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pomerantz Roger CENTRAL INDEX KEY: 0001614936 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 221157375 MAIL ADDRESS: STREET 1: 711 HARVEST HILL ROAD CITY: CHALFONT STATE: PA ZIP: 18914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viracta Therapeutics, Inc. CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2533 S COAST HWY 101 STREET 2: SUITE 210 CITY: CARDIFF STATE: CA ZIP: 92007 BUSINESS PHONE: 858-400-8470 MAIL ADDRESS: STREET 1: 2533 S COAST HWY 101 STREET 2: SUITE 210 CITY: CARDIFF STATE: CA ZIP: 92007 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 FORMER COMPANY: FORMER CONFORMED NAME: SUNESIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980501 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-10 0 0001061027 Viracta Therapeutics, Inc. VIRX 0001614936 Pomerantz Roger C/O VIRACTA THERAPEUTICS, INC. 2533 S COAST HWY 101, SUITE 210 CARDIFF CA 92007 1 0 0 0 Stock Option (Right to Buy) 3.69 2022-08-10 4 A 0 30282 0.00 A 2032-08-10 Common Stock 30282 30282 D One twelfth (1/12th) of the shares subject to the Option shall vest each month following the Vesting Commencement Date (as defined below), on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), or if earlier one hundred percent (100%) of the shares subject to the Option shall vest on the date of the Company's next annual stockholder meeting, in each case subject to the Participant continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through each such date. The Vesting Commencement Date is July 29, 2022. /s/ Daniel Chevallard, as Attorney-in-Fact 2022-08-11